189
Participants
Start Date
December 31, 2003
Primary Completion Date
June 30, 2004
Study Completion Date
July 31, 2004
NPS 1776 (800 mg)
NPS 1776 (800 mg) powder
PLACEBO
Placebo in non-carbonated fruit flavored drink (150 ml)
NPS 1776 (400 mg)
NPS1776 in powdered form to be mixed with a non-carbonated fruit flavored drink
Thomas Jefferson University Hospital/ Jefferson Headache Center, Philadelphia
Piedmont Medical Research Associates, Winston-Salem
Headache Wellness Center, Greensboro
University Clinical Research, Inc, Pembroke Pines
Medical Affiliated Research Center, Huntsville
The Neurology Clinic, Portland
Neurology Ctr. of Ohio, Toledo
Michigan Head-Pain & Neurological Institute, Ann Arbor
Diamond Headache Clinic, Chicago
Mercy Health Research, Chesterfield
Headache Care Center/ Clinvest, Springfield
Clinical Study Centers, LLC, Little Rock
Houston Headache Clinic, Houston
California Medical Clinic for Headache, Santa Monica
North County Neurological Associates, Oceanside
Clinical Innovations, Santa Ana
San Francisco Clinical Research Center, San Francisco
Neurology & Neurosurgery Associates of Tacoma, Inc., PS, Tacoma
The New England Center for Headache, Stamford
MedTrial Boston, Wellesley Hills
University of Medicine and Dentistry, New Jersey School of Osteopathic Medicine, Moorestown
Neuroscience Center of Northern New Jersey, Morristown
Lead Sponsor
Shire
INDUSTRY